So, | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  9525 of 12359  at  2/12/2019 9:07:49 AM  by

busbyre


 In response to msg 9523 by  roddog
view thread

Re: So,

BioCryst recently initiated APeX-2, a phase 3 clinical trial to test the efficacy and safety of BCX7353; and APeX-S, a trial to evaluate the long-term safety of the drug. These two trials put BioCryst on track to file for regulatory approval of BCX7353 in the second half of 2019.

Zenith-1 deals with the liquid formulation of BCX7353 that is going to treat acute HAE attacks.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 195
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...